HSS.L

HSS Hire Group Plc
HSS Hire Group PLC - Directorate Change
12th August 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9655Z
HSS Hire Group PLC
12 August 2024
 

12 August 2024

HSS Hire Group Plc

Directorate Change

 

Further to the announcement of 1 May 2024 that Paul Quested, Chief Financial Officer, will leave HSS Hire Group Plc ("HSS" or "the Group") at the end of August, HSS announces that Richard Jones has today assumed the role of interim CFO.

 

Richard has over 13 years of experience in finance roles in UK public and private companies. He is currently Senior Independent Director and Audit Committee Chair of Alliance Pharma Plc and Non-Executive Director of C4X Discovery Ltd and was most recently CFO and Company Secretary of Medica Group Plc. Prior to Medica, Richard was CFO of Mereo Biopharma Plc and previously CFO and Company Secretary of Shield Therapeutics Plc.

 

Richard will work closely with Paul over the next few weeks to ensure a smooth handover.

 

Further information relating to Richard Crispin Morgan Jones

 

The following information regarding the appointment of Richard Crispin Morgan Jones, age 58, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Current directorships and/or partnerships:

 

Alliance Pharma Plc

C4X Discovery Ltd

Medica Australia Pty

RCMJ Consultancy Ltd

 

Former directorships and/or partnerships (within the last five years):

 

Moonlight Topco Ltd

Moonlight Midco 1 Ltd

Moonlight Midco 2 Ltd

Moonlight Bidco Ltd

Medica Group Ltd (formerly Medica Group Plc)

Medica US Inc

Medica Reporting Finance Ltd

Medica Reporting Services Ltd

Medica Reporting Ltd

Medica IT Services Ltd

Global Diagnostics Ireland Ltd

Global Retinopathy Screening Ltd

JCA Seminars Ltd

Medica US Inc

Med-IDX PTY

Med-IDX UK Ltd

Mereo BioPharma Group Plc

Mereo BioPharma 1 Ltd

Mereo BioPharma 2 Ltd

Mereo BioPharma 3 Ltd

Mereo BioPharma 4 Ltd

Mereo BioPharma Ireland Ltd

Mereo US Holdings Inc

Mereo MereoCo Inc

 

There is no further information to be disclosed in relation to the director appointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules.

 

 

-Ends-

 

Notes to editors

HSS Hire Group plc provides tool and equipment hire and related services in the UK and Ireland through a nationwide network of Group companies and third-party suppliers. It offers a one-stop shop for all equipment through a combination of its complementary rental and re-hire business to a diverse, predominantly B2B customer base serving a range of end markets and activities. Over 90% of its revenues come from business customers. HSS is listed on the AIM Market of the London Stock Exchange. For more information please see www.hsshiregroup.com.

 

 

For further information, please contact:

 


HSS Hire Group plc


Steve Ashmore, Chief Executive Officer

Investors@hss.com

 

FTI Consulting LLP

Tel: 0203 727 1340

Nick Hasell

Vicky Hayns

hss@fticonsulting.com

 

Numis Securities (Nominated Adviser and Broker)

Tel: 0207 260 1000

 

Stuart Skinner

George Price


 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUGDISSGDGSC]]>
TwitterFacebookLinkedIn